Abstract: . . .  1999). M. Marin Blanco Servicio de Urgencias. Hospital El Escorial. Madrid. 1- Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of co- ronary artery disease and acute coro- nary syndromes. N Engl J Med 1992; 326:242-50,310-8. 2- Cairns JA, Lewis D Jr, Meade TW, Sutton GC, Theroux P. Antithrombotic agents in coronary artery disease. Chest 1995;108 (suppl):380S-400S. 3- Unstable Angina : Diagnosis and Ma- nagement, Clinical Practice Guideline, Number 10, AHCPR Publication Num- ber 1994-0602. May 1995. 4- Martn Luengo C, Abeytua Jimnez M, Bosch Genover X, Lpez Bescs J, Tamargo Menndez A, Tobaruela Gon- zlez A, et al. Tratamiento mdico de la angina de pecho. Rev Esp Cardiol 1995;48:447-59. 5- Weitz JI. Drug therapy: Low-molecu- lar-weight heparin. N Engl J Med 1997; 337:688-98. 6- Moya Mir MS, Calabrese Snchez S. Enfermedad tromboemblica en urgen- cias. Emergencias 1999;11:118-31. 7- Gurfinkel EP, Manos EJ, Mejail IR, Cerd MA, Duronto EA, Garca CN, et al. Low molecular weigtht heparin ver- sus regular heparin or aspirin in the tre- atement of instable angina and silent is- chemia. J Am Coll Cardiol 1995;26: 313-8. 8- Leizorovicz A. Preliminary data from FRAX.I.S Trial. Reported at the 20th European Congress of Cardiology. Vienna, Austria. 22-26 August, . . .
. . .  et al. A comperation of low- molecular -weigth heparin with infractionated he- parin for unstable coronary artery dise- ase. N Engl J Med 1997;337:447-52. 11- Cohen M. The ESSENCE Study (1 year follow up). Reported at the 47th Annual Scientific Sessions of the Ameri- can College of Cardiology. Atlanta, Ga. March 29 - April 1, 1998. 12- Antman EM. TIMI 11B. Enoxiparin versus unfraccionated heparin for uns- table angina or non-Q-wave myocardial infartation. Reported at the 20th Euro- pean Congress of Cardiology. Vienna, Austria. 22-26 August, 1998. 13- Antman EM, Cohen M, Radley D, McCabe CH, Premmereur J, Braunwald E. Enoxaparin for instable angina /non- Q-wave miocardial infartation: Meta- analysis of TIMI 11B and ESSENCE. J Am Coll Cardiol 1999;33 (Suppl A): 351. 14- Mark DB, Cowper PA, Berkowitz SD, Davidson-Ray L, DeLong ER, Turpie AGG, et al. Economic assessment of low-molecular -weight heparin (enoxapa- rin) versus unfractionated heparine in acute coronary syndrome patients. Re- sults from the ESSENCE randomized trial. Circulation 1998;97:1702-7. BIBLIOGRAFA  . . .
--3000,2,750,2919,16622